BRONCHOGENIC
CARCINOMA
Dr. Vineet Chauhan
Abstract
Brochogenic carcinoma is also called Lung cancer.
It is a frequent and important neoplasm in both
developed country and developing country.
In recent years, It is reported that lung cancer is
the leading fatal neoplasm of men and women.
It is strongly associated with the use of tobacco
products, particularly with cigarettes.
Incidence and prevalence
Commonest cancer in males and 2nd most common in
females
Occurs in 5th to 6th decade of life, uncommon before 40
Squamous cell carcinoma is thought to be the most
frequent form of the tumor(50 -70%) percent of all
cases),followed by adenocarcinoma (15%), anaplastic
( large cell carcinoma, oat cell) 20-30%, and small cell
carcinoma (1-10%).
Nowadays an increase has occurred in the incidence of
adenocarcinoma
Etiology and pathogenesis
Cigarette smoking- smoke contains polycyclic
hydrocarbons and unburned tobbacco
contains N- nitroso-nornicotine--carcinogenic
Occupational associations: asbestos,
uranium( in miners), arsenical fumes, nickel ,
radon gas etc.
Other factors include air pollutions-
sulphurous smoke , ionizing radiation
Dust laden tar
Respiratory viruses
Nowadays It is reported that tuberculosis is
associated with the incidence of lung
cancer.
Pathogenesis
Many factors influence the formation of
lung cancer. The development of
lung
cancer is multistep process.
Perhaps It is related to:
damage to cellular DNA;
alteration in cellular oncogene
expression;
tumor-derived factors that stimulate
cellular division.
Etiology and pathogenesis
Chronic inflammation of the lung,
such as from interstitial fibrosis and
areas of scarring is associated with the
occurrence of adenocarcinoma.
Genetic factors also involve the
formation of lung cancer.
Classifications
According to macroscopic variety:
(1)Main bronchus tumors
Most common variety
Arises from 1st or 2nd division of bronchus
Frequently cause bronchial obstruction
Mostly squamous cell carcinoma
(2) Peripheral tumors
Arise from small bronchi
Late in producing symptoms, detected
accidently
Mostly is adenocarcinoma.
(3) Pancoast tumors )
Peripheral tumors found in apex of lungs
Early symptoms because of invasion of
brachial plexus and sympathetic chain
Slow growing variety
Scar carcinoma
Arises from previous pulmonary disease
Tuberculosis, infarct, inflammatory lesions
Adenocarcinoma variety
Pancoast tumors
Microscopic Classification
Squamous cell carcinoma (50-70%)
Most common type.
It arises from altered bronchial epithelium
(squamous metaplasia)
It is related to cigarette smoking.
Arises from main bronchi, yet peripheral
tumors and pancoast tumors of this variety
Slow growing, bulky tumors
Involves quickly hilar, paratracheal,
subcarinal LN
Microscopic Classifications
Adenocarcinoma (15%)
It arises from the submucosal
glands,located in peripheral airways and
alveoli.
Non smokers, females
Growth rapid
Metastasize –vascular-liver, brain ,bone,
adrenals
Cannon ball tumors
Adenoca. –cannon ball
tumors
Microscopic Classifications
Undifferentiated/ anaplastic carcinoma (20-30%)
Highly aggressive type
1)Oat cell variety is most aggressive amongst these
Central location
Spread-lymphatic, disseminates to surrounding tissue
and vascular spread
2)Large cell (giant cell tumors) (1-10%)
Variant of adenocarcinoma
Aggressive tumor - peripherally located
Lymphatic spread not seen
Classification
3) Small cell carcinoma
Located peripheraly
SCLC belongs in a group of tumors
derived from neuroendocrine cells that
are responsible for the production and
secretion of specific peptide product
they may related to paraneoplastic
syndrome.
Microscopic Classifications
Bronchoalveolar/ alveolar cell carcinoma
Arises from alveolar cells or typical clara
cells in the bronchioles
Favorable prognosis compared to other
tumors
Spread
Direct extension- mediastinum, pleura,
pericardium,chest wall
Intrabronchial spread-main bronchus tumors
Lymphatic spread-
hilar- subcarinal-paratracheal-supraclavicular-
inferior deep cervical LN
In lungs-peri bronchial and perivascular
spread
Blood spread- adenocarcinomas, oat cell
,giant cell
Clinical Manifestations
Due to primary lesions:
Cough
Dyspnea
Hemoptysis
Chest pain
Clinical manifestations
Regional spread to hilar and
mediastinal nodes may cause
Invasion of mediastinum-SVC-congestion
of veins of face
Dysphagia due to esophageal compression,
Hoarseness due to recurrent laryngeal
nerve compression,
Horner’s syndrome due to sympathetic
nerve involvement
Elevation of the hemidiaphragm from
phrenic nerve compression.
Clinical manifestations
Superior sulcus, or pancoast’s tumor
may involve the brachial plexus,
resulting in a C7-T2 neuropathy with
pain, numbness, and weakness of the
arm.
Cardiac involvement is seen in About 20-
25 percent of patients
Clinical manifestations
Extrapulmonary manifestations. Including
metastasis to other organs, such as brain,
central nervous system, skeleton system, liver,
adrenal glands and lymph nodes etc.
Paraneoplastic syndromes are remote effects
of tumor.
Release of hormone like substance
They lead to metabolic and neuromuscular
disturbances unrelated to the primary tumor,
metastases, or treatment.
They may be the first sign of the tumor.
Regression of symptoms after removal of tumor
They do not indicate that a tumor has spread.
Paraneoplastic syndrome
Cushing syndrome- oat cell ca, older males
ADH produced by poorly differentiated tumors-
water retention, hyponateremia, cerebral
sysmptoms(confusion)
Carcinoid syndrome production of 5
hydroxytraptophan by oat cell ca
Parathormone- Squamous cell Ca-
hypercalcemia and mental confusion
Ectopic gonadotrophin secretion-
gynaecomastia
Hypoglycemia
Physical examinations
Usually in early stage, most of the patients with
lung cancer have no positive physical findings.
General findings include abnormal percussion,
breath sounds changes, moist rales (when
pneumonia happens)
Digital clubbing, superior vena cava syndrome,
horner’s syndrome(unilaterally constricted
pupil, enophthalmos,narrowed palpebral fissure
and loss of sweating on the same side of the
face.
Physical examinations
Endobronchial obstruction may result in
a localized wheeze
Lobar collapse may result in an area of
decreased breath sounds and dullness to
percussion.
( Central bronchogenic carcinoma)
Diagnosis of Bronchogenic
carcinoma
Abstract
Diagnosis of lung cancer requires:
A: Detecting the tumor
B: Establish the cell type - histology
C: Define the stage of the tumor
Determining the cell type is most important
because it influences the treatment.
Many methods we used to detect the tumor, including
Chest X-ray,
Computer Tomo graphy(CT),
Magnetic resonace imaging (MRI),
PET (Positron emmision tomography)
Histologic examination
sputum examination
bronchoscopy -biopsy,bronchial brushing , bronchial
washings, transbronchial needle aspiration
transthoracic needle aspiration
If a diagnosis is not established by these
imaging examination and cytologic study , we
can use thoracoscopy/ thoracotomy.
Chest X-ray
•It is the most important method to find lung cancer.
•If a patient with chronic cough, sputum with few
blood, and dyspnea, lower fever he should adopt a
chest X-ray.
•The most frequent finding is a mass in the lung field.
On chest X-ray, secondary manifestations include
•lobar collapse,
•pleural effusion,
•pneumonitis,
•elevation of the hemidiaphragm,
•hilar and mediastinal adenopathy, and
•erosion of ribs or vertebrae due to metastases.
Lung cancer on CT
CT is the most useful in evaluating patients with
pulmonary and mediastinal masses.
It is also useful for detecting multiple metastases.
CT can show a mass to be located in which lobe of
lung field and the size of the mass.
It also shows the nodule in the mediastinum.
Sometimes,when a mass locate behind the heart, chest
X-ray can`t detect .
( Peripheral carcinoma)
Bronchoscopy
It is important both for determining if a tumor
is present and for obtaining tissue for histologic
diagnosis.
Usually, the combination of bronchial brushing
and forceps biopsy is positive 90 to 93 percent
of the tumors located in proximal airway.
CT guided lung biopsy
• Transthoracic needle with guidance
by CT can be used to detect lesions
located near the chest wall
Thoracoscopy /Thoracotomy
If the methods mentioned above are not useful for
detecting the cell type of lung cancer,
thoracoscopy/thoracotomy may be used.
In some circumstances,a histologic diagnosis
can be made by biopsy of metastatic
sites,such as lymphy nodes,
liver, bone or bone marrow.
Other laboratory examinations some
tumor markers
(CEA .CA199. CA211. )
Blood IX- eosinophilia
Staging of lung carcinoma
AJCCS (American joint committee for cancer
staging)
Occult carcinoma-no evidence of primary tumor or
metastasis but brochopulmonary secretions
contain malignant cells
Invasive carcinoma-
Stage1-primary tumor w/o metastasis to LN or
distant sites
Stage 2-tumor metastasis to ipsilateral hilar LN
Stage 3- tumor metastasis to contralateral hilar
region, mediastinum, or with distant metastasis
Treatment
Includes
A:Surgery
B:Chemotherapy
C:Radiation therapy
D:Other therapy
Immunologic therapy,
Laser
Surgery
Surgical removal of primary tumor is the
treatment of choice
Contraindications of operability
Involvement of main bronchus within 1.5 cm of
carina
Invovement of oesophagus, RLN, SVC, phrenic nerve
Trachea compression
Vocal cord involvement
Distant meatstasis
Unfit for operation, poor respiratory reserve, cardiac
disease
Surgery
Radical resections depending on location
of tumor
Radical lobectomy- confined to one lobe
Radical pneumonectomy- involvement of
main bronchus
Other operations include
Local wedge resection and sleeve
resection in cases of poor respiratory
reserve
Surgery
Non-small cell lung cancer:
Stage I and II are considered candidates for
surgical resection
Stage III cancer may be candidates for
surgery with postoperative radiation of the
mediastinum.
Surgery
More than 90 percent of small cell lung cancer
has often metastasized at the time of diagnosis.
Radiation therapy or chemotherapy to be
considered before surgery.
Chemotherapy
Role to play in small cell Ca(oat cell)
Aggressive chemo is treatment of choice
Cyclophophamide, doxorubucin, and
vincristin Adriamycin
Chemo given in conjugation with
radiotherapy
Non small cell Ca
Role of chemo variable
More effective in Adeno Ca than Sq. Ca
Radiotherapy
Given to those in whom surgery is
contraindicated
Refuse surgery
Recurrence after surgery
As an adjuvant to surgery
5000-6000rads 5times weekly for 5 weeks
Preoperative RT- Pancoast tumors
Post-operative- tumor left in surgery
Palliative RT- severe chest pain, bony
metastasis
Others
Immunological therapy
BCG injected intra tumoral can be given
bronchoscopically, CT guided
Laser therapy
YAG laser (yttrium aluminium garnet)
can be used for inoperable lesions/
massive haemoptysis
Secondary Carcinoma
Metastasis from
Carcinomas- breast, kidney , thyroid,
colon ,prostate testis, uterus
Sarcomas-osteosarcoma
Choriocarcinoma
Malignant melanoma
Secondary Carcinoma
Spread
Blood borne
Lymphatic
Types
Solitary central deposit
Multiple deposits- unilateral /bilateral (cannon
ball)
Treatment
Solitary deposit- surgery
Chemotherapy and radiotherapy